secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158417
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma closes $1.5B senior notes offering across three tranches
-----------------------------------------------------------------------

- Issued $500M 5.150% notes due 2029, $500M 5.400% notes due 2034, $500M 5.900% notes due 2054.
- Interest payable semiannually on March 2 and September 2, starting March 2025.
- Notes are senior unsecured guaranteed by Royalty Pharma Holdings Ltd.
- Issuer may redeem notes at specified prices; change-of-control repurchase provisions apply.
- Offering closed June 10, 2024; aggregate principal $1.5B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524158417/0001193125-24-158417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524158417/d851509d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer